Mariana Castanheira
0000-0003-0126-1782
Publication & Citation Trends
Publications
0 total
Evaluation of an in vivo pulmonary aspergillosis model for triazole susceptibility breakpoint development
Cited by 0
Semantic Scholar
P-1314. Activity of aztreonam-avibactam against Enterobacterales isolated from patients with intra-abdominal infection from Europe, Asia, and Latin America (2020-2024)
Cited by 0
Semantic Scholar
P-1697. Performance of the VITEK 2 with Advanced Expert System as a fast method for determination of antimicrobial susceptibility against 400 Enterobacterales isolates from North and Latin America (2022)
Cited by 0
Semantic Scholar
Antimicrobial Susceptibility of Pseudomonas aeruginosa from Elderly Patients in Intensive Care Units of United States Medical Centers (2021–2025)
Cited by 0
Semantic Scholar
P-1194. Activity of manogepix against mould isolates collected from the US in 2023
Cited by 0
Semantic Scholar
P-1319. Antimicrobial Activity of Aztreonam-Avibactam and Molecular Characterization of Enterobacterales Resistant to Ceftazidime-Avibactam and/or Meropenem-Vaborbactam from United States Medical Centers (2016-2024)
Cited by 0
Semantic Scholar
P-1213. Activity of Tebipenem Against Enterobacterales, Including Molecularly Characterized Clinical Isolates Causing Urinary Tract and Bloodstream Infections from the United States in 2023
Cited by 0
Semantic Scholar
P-1193. Activity of isavuconazole against contemporary Mucorales from a worldwide surveillance program
Cited by 0
Semantic Scholar
Research Topics
Antibiotic Resistance in Bacteria
(371)
Antibiotics Pharmacokinetics and Efficacy
(190)
Antibiotic Use and Resistance
(159)
Antifungal resistance and susceptibility
(131)
Bacterial Identification and Susceptibility Testing
(112)
Affiliations
Statens Serum Institut
Tufts University
National Institute of Engineering, Technology and Innovation
University of Iowa
Merck & Co., Inc., Rahway, NJ, USA (United States)